Posted by Michael Wonder on 17 May 2025
MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis
15 May 2025 - The MHRA has today approved a vaccine (Capvaxive) for people aged 18 years and older to help protect against illnesses caused by bacteria called Streptococcus pneumoniae or pneumococcus.
This vaccine has been approved through the International Recognition Procedure (IRP). The IRP allows the MHRA to take into account the expertise and decision-making of trusted regulatory partners for the benefit of UK patients.
